Elizabeth Repasky

459 total citations
13 papers, 372 citations indexed

About

Elizabeth Repasky is a scholar working on Molecular Biology, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Elizabeth Repasky has authored 13 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Psychiatry and Mental health. Recurrent topics in Elizabeth Repasky's work include Cancer, Stress, Anesthesia, and Immune Response (5 papers), Heat shock proteins research (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Elizabeth Repasky is often cited by papers focused on Cancer, Stress, Anesthesia, and Immune Response (5 papers), Heat shock proteins research (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Elizabeth Repasky collaborates with scholars based in United States, India and United Kingdom. Elizabeth Repasky's co-authors include Ezogelin Oflazoglu, Francisco J. Hernandez‐Ilizaliturri, Julie R. Ostberg, Myron S. Czuczman, John R. Subjeck, Ian Rivens, Gail ter Haar, Latif Kazim, Xing Chen and Yoshiyuki Kaneko and has published in prestigious journals such as Cancer Research, FEBS Letters and Breast Cancer Research and Treatment.

In The Last Decade

Elizabeth Repasky

13 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Repasky United States 7 154 146 122 84 51 13 372
Felipe Vences‐Catalán United States 12 235 1.5× 228 1.6× 110 0.9× 46 0.5× 21 0.4× 17 505
Mingmei Cai United States 8 135 0.9× 253 1.7× 182 1.5× 17 0.2× 21 0.4× 15 456
Gerald Moncayo Switzerland 10 131 0.9× 321 2.2× 76 0.6× 21 0.3× 34 0.7× 12 532
Hok Seon Kim United States 8 204 1.3× 207 1.4× 129 1.1× 221 2.6× 27 0.5× 11 488
Mathias Krohn Germany 10 32 0.2× 100 0.7× 161 1.3× 60 0.7× 38 0.7× 20 367
Siwen Liu China 15 76 0.5× 408 2.8× 131 1.1× 23 0.3× 28 0.5× 37 637
Giulia Chiaruttini United Kingdom 7 203 1.3× 188 1.3× 166 1.4× 34 0.4× 10 0.2× 10 446
Priyamvada Jayaprakash United States 10 296 1.9× 295 2.0× 228 1.9× 27 0.3× 10 0.2× 14 679
Xiangyi Shi China 10 156 1.0× 164 1.1× 70 0.6× 17 0.2× 26 0.5× 15 407
Yangyi Bao China 9 220 1.4× 90 0.6× 229 1.9× 42 0.5× 12 0.2× 17 346

Countries citing papers authored by Elizabeth Repasky

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Repasky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Repasky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Repasky more than expected).

Fields of papers citing papers by Elizabeth Repasky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Repasky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Repasky. The network helps show where Elizabeth Repasky may publish in the future.

Co-authorship network of co-authors of Elizabeth Repasky

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Repasky. A scholar is included among the top collaborators of Elizabeth Repasky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Repasky. Elizabeth Repasky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Repasky, Elizabeth & Hemn Mohammadpour. (2025). Targeting nerve growth factor: an Achilles’ heel for tumors?. Journal for ImmunoTherapy of Cancer. 13(5). e011609–e011609. 4 indexed citations
2.
Gupta, Ashish, Arya Mariam Roy, Kush Gupta, et al.. (2024). Impact of environmental temperature on the survival outcomes of breast cancer: A SEER-based study. Breast Cancer Research and Treatment. 207(2). 383–392. 3 indexed citations
3.
Gupta, Kush, Kristopher Attwood, Ashish Gupta, et al.. (2023). Association between Environmental Temperature and Survival in Gastroesophageal Cancers: A Population Based Study. Cancers. 16(1). 74–74. 3 indexed citations
4.
Rivens, Ian, et al.. (2021). Pulsed focused ultrasound can improve the anti-cancer effects of immune checkpoint inhibitors in murine pancreatic cancer. Journal of The Royal Society Interface. 18(180). 20210266–20210266. 40 indexed citations
5.
Gandhi, Shipra, Manu Pandey, Chong Wang, et al.. (2020). Impact of Concomitant Medication Use and Immune-Related Adverse Events on Response to Immune Checkpoint Inhibitors. Immunotherapy. 12(2). 141–149. 25 indexed citations
6.
Drummond, Daryl C., Michael T. Moser, Walid S. Kamoun, et al.. (2016). Abstract 2069: Activity of an EphA2-targeted docetaxel nanoliposome in pancreatic patient-derived models as monotherapy and in combination with gemcitabine. Cancer Research. 76(14_Supplement). 2069–2069. 1 indexed citations
7.
Wee, Wen, Hao Zhang, Bonnie L. Hylander, et al.. (2012). Abstract 1939: TL32711, a novel Smac mimetic, exerts significant antitumor efficacy in primary pancreatic adenocarcinoma model. Cancer Research. 72(8_Supplement). 1939–1939. 3 indexed citations
8.
Shao, Huanjie, Haikuo Tang, Oreste E. Salavaggione, et al.. (2011). Improved Response to nab-Paclitaxel Compared with Cremophor-Solubilized Paclitaxel is Independent of Secreted Protein Acidic and Rich in Cysteine Expression in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 6(6). 998–1005. 27 indexed citations
9.
Hernandez‐Ilizaliturri, Francisco J., et al.. (2003). Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.. PubMed. 9(16 Pt 1). 5866–73. 160 indexed citations
10.
Li, Ying, et al.. (2002). Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor. Cancer Immunology Immunotherapy. 51(6). 311–319. 31 indexed citations
11.
Wang, Tongtong, Deborah Hopkins, Li-Qun Fan, et al.. (2001). A p53 homologue and a novel serine proteinase inhibitor are over-expressed in lung squamous cell carcinoma. Lung Cancer. 34(3). 363–374. 6 indexed citations
12.
Chen, Xing, et al.. (2000). Characterization of native interaction of hsp110 with hsp25 and hsc70. FEBS Letters. 465(2-3). 98–102. 44 indexed citations
13.
Wang, Xiangyang, Yoshiyuki Kaneko, Elizabeth Repasky, & John R. Subjeck. (2000). Heat Shock Proteins and Cancer Immunotherapy. Immunological Investigations. 29(2). 131–137. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026